Medicure (OTCMKTS:MCUJF) Share Price Crosses Below 200 Day Moving Average – Should You Sell?

Medicure Inc. (OTCMKTS:MCUJFGet Free Report)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.68 and traded as low as $0.52. Medicure shares last traded at $0.54, with a volume of 17,650 shares trading hands.

Medicure Stock Performance

The company has a current ratio of 2.03, a quick ratio of 1.64 and a debt-to-equity ratio of 0.03. The firm’s fifty day moving average is $0.62 and its 200 day moving average is $0.68. The company has a market cap of $5.66 million, a PE ratio of -3.87 and a beta of 1.00.

Medicure (OTCMKTS:MCUJFGet Free Report) last issued its quarterly earnings results on Monday, November 25th. The company reported $0.05 earnings per share for the quarter. Medicure had a negative net margin of 9.62% and a negative return on equity of 10.12%.

About Medicure

(Get Free Report)

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.

Further Reading

Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.